Change in bowel habit: what’s the diagnosis?
Dr Michael Sproat uses five hypothetical case studies to explore possible causes of a change in bowel habit and how to diagnose and manage these in primary care
Diagnose and treat pancreatic exocrine insufficiency in diabetes
Dr Kate Millar and Professor Michael Cummings present a summary of guidance that aims to help practitioners to identify and manage pancreatic exocrine insufficiency in people with diabetes
Key learning points: NICE diverticular disease
Dr Michael Sproat identifies five key learning points for primary care from the 2019 NICE guideline on the diagnosis and management of diverticular disease
Top tips: GORD in infants, children, and young people
Dr Jennifer Parkhouse offers 10 top tips on identifying and managing gastro-oesophageal reflux disease in children
Unintended weight loss: what’s the diagnosis?
Dr Sonya Jey explains the importance of considering and excluding sinister causes of unintentional weight loss and explores some clinical scenarios in which unintentional weight loss is a feature
Test and reflect
Our multiple-choice questions (MCQs) are designed to help you test your knowledge and reflect on your learning after reading an article.
Patient scenarios: NICE diverticular disease
The following case studies, written by Dr Michael Sproat relate to his expert article, Key learning points: NICE diverticular disease.
Patient scenarios: GORD in children
The following case studies, written by Dr Jennifer Parkhouse relate to her expert article, Top tips: GORD in children.
IBD UK inflammatory bowel disease standards
This CPD activity consists of 5 multiple-choice questions (MCQs) designed to test your knowledge on inflammatory bowel disease.
Inflammatory bowel disease
This CPD activity consists of 5 multiple-choice questions (MCQs) designed to test your knowledge on inflammatory bowel disease (IBD) in primary care—you will then be prompted to reflect on your learning.
Educational resources
Switching from intravenous to subcutaneous infliximab biosimilar (Remsima®) in adult patients with inflammatory bowel disease: experience at an NHS trust
This supplement has been commissioned and funded by Celltrion Healthcare UK Ltd and developed in partnership with Guidelines in Practice.
View prescribing information
CTHC-UK-219D
Implementing the clinical guideline on pancreatic exocrine insufficiency in diabetes
Information intended for healthcare professionals only.